Linagliptin 5 mg & Dapagliflozin 10 mg ''''"'"

Linagliptin 5 mg & Dapagliflozin 10 mg
LINALIGLIP DAPA 5-10  
Linagliptin is a medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor.
Its primary function is to increase the levels of incretin hormones in the body, such as glucagon-like peptide-1 (GLP-1), which stimulate insulin release and decrease the production of glucagon, a hormone that raises blood sugar levels.
Linagliptin is typically taken orally, usually once daily.
Dapagliflozin belongs to a class of medications known as sodium-glucose co-transporter 2 (SGLT-2) inhibitors.
Its primary mode of action is to inhibit the SGLT-2 protein in the kidneys, which results in the excretion of excess glucose in the urine. This leads to lower blood sugar levels.
Dapagliflozin is also taken orally, typically once a day.
It is used as an adjunct to diet and exercise to help improve glycemic control in people with type 2 diabetes.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-dapa-5-10-134320